JCI - Citations to Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.

Citations to this article

Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.

F H Durie, … , L D Fast, R J Noelle

F H Durie, … , L D Fast, R J Noelle

Published September 1, 1994
Citation Information: J Clin Invest. 1994;94(3):1333-1338. https://doi.org/10.1172/JCI117453.

View: Text | PDF

Research Article

Total citations by year

Year:	2022	2019	2018	2017	2016	2015	2014	2013	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	Total
Citations:	3	1	2	1	5	3	1	2	3	2	17	2	4	3	1	3	12	9	13	5	9	11	14	17	3	1	147

Citation information

Citations to this article (147)

Title and authors	Publication	Year
A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice A Saha, S Hyzy, T Lamothe, K Hammond, N Clark, L Lanieri, P Bhattarai, R Palchaudhuri, G Gillard, J Proctor, M Riddle, A Panoskaltsis-Mortari, M MacMillan, J Wagner, H Kiem, L Olson, B Blazar	Blood	2022
siRNA against CD40 delivered via a fungal recognition receptor ameliorates murine acute graft-versus-host disease. Heissig B, Salama Y, Tateno M, Takahashi S, Hattori K		2022
Antibody based conditioning for allogeneic hematopoietic stem cell transplantation. Saha A, Blazar BR	Frontiers in immunology	2022
MicroRNAs as Potential Diagnostic, Prognostic, and Predictive Biomarkers for Acute Graft-versus-Host Disease J Motaei, M Yaghmaie, M Ahmadvand, H Pashaiefar, MA Kerachian	Biology of Blood and Marrow Transplantation	2019
Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease S Atarod, J Norden, LA Bibby, A Janin, P Ratajczak, C Lendrem, KF Pearce, XN Wang, S OReilly, JM Laar, M Collin, AM Dickinson, RE Crossland	Frontiers in immunology	2018
Characterization of grass carp CD40 and CD154 genes and the association between their polymorphisms and resistance to grass carp reovirus XB Lu, YX Chen, ZW Cui, XY Zhang, LF Lu, S Li, XQ Xia, P Nie, YA Zhang	Fish & Shellfish Immunology	2018
Lupus WA Khan	Lupus	2017
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies N Villa, M Rahman, G McFadden, C Cogle	Viruses	2016
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview M Boieri, P Shah, R Dressel, M Inngjerdingen	Frontiers in immunology	2016
Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation S Servais, Y Beguin, L Delens, G Ehx, G Fransolet, M Hannon, E Willems, S Humblet-Baron, L Belle, F Baron	Expert Opinion on Investigational Drugs	2016
Functional antagonism of human CD40 achieved by targeting a unique species-specific epitope AP Yamniuk, A Suri, SR Krystek, J Tamura, V Ramamurthy, R Kuhn, K Carroll, C Fleener, R Ryseck, L Cheng, Y An, P Drew, S Grant, SJ Suchard, SG Nadler, JW Bryson, S Sheriff	Journal of Molecular Biology	2016
Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade I Vogel, B Verbinnen, SV Gool, JL Ceuppens	Journal of immunology (Baltimore, Md. : 1950)	2016
Flow cytometric analysis of the graft-versus-Leukemia-Effect After Hematopoietic Stem Cell Transplantation in Mice: Flow Cytometric Analysis of the Graft-Versus-Leukemia-Effect F Schmidt, N Hilger, C Oelkrug, E Svanidze, P Ruschpler, W Eichler, A Boldt, F Emmrich, S Fricke	Cytometry Part A	2015
Lymph Node Stromal Fiber ER-TR7 Modulates CD4+ T Cell Lymph Node Trafficking and Transplant Tolerance: BE Burrell, KJ Warren, Y Nakayama, D Iwami, CC Brinkman, JS Bromberg	Transplantation	2015
JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter AH Wagner, M Conzelmann, F Fitzer, T Giese, K Gülow, CS Falk, OH Krämer, S Dietrich, M Hecker, T Luft	Biochemical Pharmacology	2015
Laminins affect T cell trafficking and allograft fate Kristi Warren, Daiki Iwami, Donald Harris, Jonathan Bromberg, Bryna Burrell	Journal of Clinical Investigation	2014
Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation KA Markey, KP MacDonald, GR Hill	Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation	2013
Importance of reverse signaling of the TNF superfamily in immune regulation K Juhász, K Buzás, E Duda	Expert Review of Clinical Immunology	2013
Mouse models of graft-versus-host disease: advances and limitations MA Schroeder, JF DiPersio	Disease models & mechanisms	2011
T-Cell Costimulatory Molecules in Acute-Graft-Versus Host Disease: Therapeutic Implications J Briones, S Novelli, J Sierra	Bone Marrow Research	2011
Advances in Immunology E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné	Advances in Immunology Volume 110	2011
Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease B Kwon	Experimental & molecular medicine	2010
Methods in Microbiology V Tchikov, J Fritsch, D Kabelitz, S Schütze	Methods in Microbiology	2010
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
Therapeutic Targets of the TNF Superfamily IS Grewal		2009
1α,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes C Almerighi, A Sinistro, A Cavazza, C Ciaprini, G Rocchi, A Bergamini	Cytokine	2009
A double-edged sword in B-cell-targeted therapy for inflammatory diseases J Mizuguchi	Expert Review of Clinical Immunology	2009
Principles of Cancer Biotherapy RK Oldham, RO Dillman		2009
CD154-CD40 Interactions Are Essential for Thymus-Dependent Antibody Production in Zebrafish: Insights into the Origin of Costimulatory Pathway in Helper T Cell-Regulated Adaptive Immunity in Early Vertebrates YF Gong, LX Xiang, JZ Shao	Journal of immunology (Baltimore, Md. : 1950)	2009
Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues YW Chu, RE Gress	Biology of Blood and Marrow Transplantation	2008
Viral Infection: A Potent Barrier to Transplantation Tolerance DM Miller, TB Thornley, DL Greiner, AA Rossini	Clinical and Developmental Immunology	2008
sCD40 Ligand Determined in Maternal and Umbilical Cord Blood in Pregnancies Complicated by Pre-Eclampsia with and without Intrauterine Growth Retardation M Laskowska, K Laskowska, B Leszczy&nacute;ska-Gorzelak, J Oleszczuk	Gynecologic and Obstetric Investigation	2007
B cell targeted therapy in autoimmunity M Blank, Y Shoenfeld	Journal of Autoimmunity	2007
Platelets as Mediators of Inflammation SR Steinhubl	Hematology/Oncology Clinics of North America	2007
Resistance to the Induction of Mixed Chimerism in Spontaneously Diabetic NOD Mice Depends on the CD40/CD154 Pathway and Donor MHC Disparity B Luo, T Wu, Y Pan, H Sozen, J Hao, Y Zhang, DE Sutherland, BJ Hering, Z Guo	Annals of the New York Academy of Sciences	2007
Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice H Masaki, MC Appel, L Leahy, J Leif, L Paquin, LD Shultz, JP Mordes, DL Greiner, AA Rossini	Xenotransplantation	2006
Activation-associated phenotype of CD3+ T cells in acute graft-versus-host disease MP Morante, J Briones, E Canto, H Sabzevari, R Martino, J Sierra, JL Rodriguez-Sanchez, S Vidal	Clinical & Experimental Immunology	2006
Shared biology of GVHD and GVT effects: Potential methods of separation DH Fowler	Critical Reviews in Oncology/Hematology	2006
Current controversies in oral lichen planus: Report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis G Lodi, C Scully, M Carrozzo, M Griffiths, PB Sugerman, K Thongprasom	Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology	2005
Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway P Han, T McDonald, G Hodge	Immunology	2004
β2-Adrenergic receptor agonist induces IL-18 production without IL-12 production HK Takahashi, H Iwagaki, S Mori, T Yoshino, N Tanaka, M Nishibori	Journal of Neuroimmunology	2004
Graft vs. Host Disease, Third Edition C Liu, J Crawford	Graft vs. Host Disease, Third Edition	2004
Hematopoietic chimerism and central tolerance created by peripheral tolerance induction without myeloablative conditioning Edward Seung, John P. Mordes, Aldo A. Rossini, Dale L. Greiner	Journal of Clinical Investigation	2003
Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis AJ Ruth, AR Kitching, TJ Semple, PG Tipping, SR Holdsworth	Journal of the American Society of Nephrology : JASN	2003
The complementary roles of deletion and regulation in transplantation tolerance RI Lechler, OA Garden, LA Turka	Nature Reviews Immunology	2003
Suppression of the Immune Response Against Exogenous Desmoglein 3 in Desmoglein 3 Knockout Mice: An Implication for Gene Therapy M Ohyama, T Ota, M Aoki, K Tsunoda, R Harada, S Koyasu, T Nishikawa, M Amagai	Journal of Investigative Dermatology	2003
New advances in acute graft-versus-host disease prophylaxis JK Davies, MW Lowdell	Transfusion Medicine	2003
Blockade of the CD40/CD154 pathway enhances T???cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy Y Pan, B Luo, H Sozen, H Kalscheuer, BR Blazar, DE Sutherland, BJ Hering, Z Guo	Transplantation	2003
LIGHT–HVEM signaling and the regulation of T cell-mediated immunity SW Granger, S Rickert	Cytokine & Growth Factor Reviews	2003
Antigen presentation in graft-vs-host disease WD Shlomchik	Experimental Hematology	2003
Tolerance induction by costimulator blockade in 100 cGy treated hosts with varying degrees of genetic disparity M Abedi, D Greer, JF Lambert, GA Colvin, MS Dooner, CI McAuliffe, D Demers, BE Moore, PJ Quesenberry	Leukemia	2003
CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium KM Omari, K Dorovini-Zis	Journal of Neuroimmunology	2003
Pancreatitis-Associated Acute Lung Injury CM Pastor, MA Matthay, JL Frossard	Chest	2003
CD154 Transcriptional Regulation in Primary Human CD4 T Cells RQ Cron	Immunologic Research	2003
Prevention of Graft-Versus-Host Diseases and the Induction of Host-Specific T Cell Anergy by Soluble Lymphotoxin-beta Receptor and Anti-CD40 Ligand Antibody Koji Tamada, Hideto Tamura, Dallas Flies, Yang-Xin Fu, Esteban Celis, Larry R. Pease, Bruce R. Blazar, Lieping Chen	Journal of Clinical Investigation	2002
Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis J Ohata, J Sakurai, K Saito, K Tani, S Asano, M Azuma	Clinical & Experimental Immunology	2002
Selective Requirement for CD40-CD154 in Drug-Induced Type 1 Versus Type 2 Responses to Trinitrophenyl-Ovalbumin S Nierkens, P van Helden, M Bol, R Bleumink, P van Kooten, S Ramdien-Murli, L Boon, R Pieters	Journal of immunology (Baltimore, Md. : 1950)	2002
Suppressor of Cytokine Signaling 1 Inhibits Cytokine Induction of CD40 Expression in Macrophages DR Wesemann, Y Dong, GM OKeefe, VT Nguyen, EN Benveniste	Journal of immunology (Baltimore, Md. : 1950)	2002
Understanding the alloresponse: New approaches to graft-versus-host disease prevention T Teshima, JL Ferrara	Seminars in Hematology	2002
Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation M Cavazzana-Calvo, I André-Schmutz, S Hacein-Bey-Abina, D Bensoussan, FL Deist, A Fischer	Seminars in Hematology	2002
Donor Lymphocyte Infusions to Treat Hematologic Malignancies in Relapse after Allogeneic Blood or Marrow Transplantation L Luznik, EJ Fuchs	Cancer control : journal of the Moffitt Cancer Center	2002
A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection1: X Yuan, VM Dong, AJ Coito, AM Waaga, AD Salama, CD Benjamin, MH Sayegh, A Chandraker	Transplantation	2002
CD40 Ligand-Deficient T Cells from X-Linked Hyper-IgM Syndrome Carriers Have Intrinsic Priming Capability FM Lobo, PR Scholl, RL Fuleihan	Journal of immunology (Baltimore, Md. : 1950)	2002
Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis SL Kalled, AH Cutler, JL Ferrant	Lupus	2001
Pathogenesis and prevention of graft-versus-host disease T Teshima, JL Ferrara	Current Opinion in Organ Transplantation	2001
POTENTIAL BIOLOGIC AGENTS FOR TREATING RHEUMATOID ARTHRITIS LW Moreland	Rheumatic Disease Clinics of North America	2001
CD154 DEFICIENCY AND RELATED SYNDROMES FA Bonilla, RS Geha	Immunology and Allergy Clinics of North America	2001
Function of CD40/CD40L in peritubular capillary of renal allograft rejection Y Ohashi, H Okazaki, T Sato, S Miura, N Amada, M Yamaguchi	Transplantation Proceedings	2001
Manipulation of costimulatory pathways in autoimmune diseases A Nakajima	Modern Rheumatology	2001
CD40 Ligand—an important target for immunotherapy? ML Huggins, I Todd, RJ Powell	Lupus	2001
Co-Stimulatory Blockade and Tolerance Induction in Transplantation: A Bartlett, J McCall, S Munn	BioDrugs	2001
Therapeutic Immunosuppression AW Thomson		2001
Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice PJ Quesenberry, S Zhong, H Wang, M Stewart	Blood	2001
Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions PA Taylor, CJ Lees, H Waldmann, RJ Noelle, BR Blazar	Blood	2001
Preferential Blockade of CD8 + T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases K Nozawa, J Ohata, J Sakurai, H Hashimoto, H Miyajima, H Yagita, K Okumura, M Azuma	Journal of immunology (Baltimore, Md. : 1950)	2001
Role of CD28/CD80-86 and CD40/CD154 Costimulatory Interactions in Host Defense to Primary Herpes Simplex Virus Infection KH Edelmann, CB Wilson	Journal of virology	2001
Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice E Seung, N Iwakoshi, BA Woda, TG Markees, JP Mordes, AA Rossini, DL Greiner	Blood	2000
Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration YP de Jong, M Comiskey, SL Kalled, E Mizoguchi, RA Flavell, AK Bhan, C Terhorst	Gastroenterology	2000
Signal Transduction and the Coordination of B Lymphocyte Development and Function II LB Justement, KA Siminovitch		2000
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10 D Rea, C van Kooten, KE van Meijgaarden, TH Ottenhoff, CJ Melief, R Offringa	Blood	2000
Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation N Tsukada, H Akiba, T Kobata, Y Aizawa, H Yagita, K Okumura	Blood	2000
The Effect of Anti-gp39 Treatment on the Intestinal Manifestations of Acute Murine Graft-versus-Host Disease E Stüber, A Freier, UR Fölsch	Clinical Immunology	1999
Immune Reactivity Following CD40L Blockade: Role in Autoimmune Glomerulonephritis in Susceptible Recipients N Banu, Y Zhang, CM Meyers	Autoimmunity	1999
Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 NS Kenyon, M Chatzipetrou, M Masetti, A Ranuncoli, M Oliveira, JL Wagner, AD Kirk, DM Harlan, LC Burkly, C Ricordi	Proceedings of the National Academy of Sciences	1999
Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues H Wu, Y Nie, WD Huse, JD Watkins	Journal of Molecular Biology	1999
On costimulatory signals and T cell tolerance: relevance for transplantation immunity GA Holländer, S Zuklys, E Förster, W Krenger	Transplantation Proceedings	1999
Induction of Immunologic Tolerance for Transplantation AA Rossini, DL Greiner, JP Mordes	Physiological reviews	1999
Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor ? and CD40 signals M Kitagawa, H Mitsui, H Nakamura, S Yoshino, S Miyakawa, N Ochiai, M Onobori, H Suzuki, T Sumida	Arthritis & Rheumatism	1999
Advances in Allogeneic Hematopoietic Stem Cell Transplantation RK Burt, MM Brush		1999
Rapid Induction of CD40 on a Subset of Granulocyte Colony-Stimulating Factor–Mobilized CD34+ Blood Cells Identifies Myeloid Committed Progenitors and Permits Selection of Nonimmunogenic CD40− Progenitor Cells D Rondelli, RM Lemoli, M Ratta, M Fogli, F Re, A Curti, M Arpinati, S Tura	Blood	1999
Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4 TG Markees, NE Phillips, EJ Gordon, RJ Noelle, LD Shultz, JP Mordes, DL Greiner, AA Rossini	Journal of Clinical Investigation	1998
CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses BR Blazar, PA Taylor, RJ Noelle, DA Vallera	Journal of Clinical Investigation	1998
The hyper-IgM (HIM) syndrome N Ramesh, M Seki, LD Notarangelo, RS Geha	Springer Seminars in Immunopathology	1998
Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells K Clodi, Z Asgary, S Zhao, KO Kliche, F Cabanillas, M Andreeff, A Younes	British Journal of Haematology	1998
The role of B7 co-stimulation in activation and differentiation ofCD4+and CD8+T cells AJ Adam, AN Schweitzer, AH Sharpe	Immunological Reviews	1998
Interactions between T lymphocytes and endothelial cells in allograft rejection DM Briscoe, SI Alexander, AH Lichtman	Current Opinion in Immunology	1998
Advances in Protein Chemistry CM Silva, J Isgaard, MO Thorner	Advances in Protein Chemistry	1998
Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies Y Seko, N Takahashi, M Azuma, H Yagita, K Okumura, Y Yazaki	Circulation research	1998
Blockade of Cd40-Cd154 Interferes with Human T cell Engraftment in Scid Mice TM Foy, M Mcilraith, SR Masters, JJ Dunn, AA Rossini, LD Shultz, RA Hesselton, EJ Wagar, PE Lipsky, RJ Noelle, DL Greiner	Cell Transplantation	1998
Therapeutic Strategies for Modulating the Inflammatory Diseases BM Weichman, AJ Main, L Marshall, J Winkler, LG Letts		1998
Recombinant CD40L Treatment Protects Allogeneic Murine Bone Marrow Transplant Recipients From Death Caused by Herpes Simplex Virus-1 Infection JL Beland, H Adler, NC Del-Pan, W Kozlow, J Sung, W Fanslow, IJ Rimm	Blood	1998
Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice S Funakoshi, DD Taub, MR Anver, A Raziuddin, O Asai, V Reddy, H Rager, WC Fanslow, DL Longo, WJ Murphy	Journal of Clinical Investigation	1997
Systemic lupus: basic mechanisms and prospects for specific immunotherapy SK Datta	Japanese Journal of Rheumatology	1997
Biologic agents for treating rheumatoid arthritis. Concepts and progress LW Moreland, LW Heck, WJ Koopman	Arthritis & Rheumatism	1997
The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation WJ Murphy, DL Longo	Immunological Reviews	1997
Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney C Kooten, JS Gerritsma, ME Paape, LA van Es, J Banchereau, MR Daha	Kidney International	1997
The CD40 pathway in allograft rejection, acceptance, and tolerance CP Larsen, TC Pearson	Current Opinion in Immunology	1997
Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity A Tang, TA Judge, LA Turka	European Journal of Immunology	1997
CD40 and Its Ligand in Autoimmimity RJ Noelle, M Mackey, T Foy, J Buhlmann, C Burns	Annals of the New York Academy of Sciences	1997
Functions of CD40 on B cells, dendritic cells and other cells C Kooten, J Banchereau	Current Opinion in Immunology	1997
Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction G Carayanniotis, SR Masters, RJ Noelle	Immunology	1997
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis F Mach, U Schönbeck, GK Sukhova, T Bourcier, JY Bonnefoy, JS Pober, P Libby	Proceedings of the National Academy of Sciences	1997
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis F Mach, U Schonbeck, GK Sukhova, T Bourcier, JY Bonnefoy, JS Pober, P Libby	Proceedings of the National Academy of Sciences	1997
Detachment Activity but Not Cytotoxicity Induced in a T-Cell Clone Following Antigen Presentation in the Presence of Thymic Epithelial Cells R Kaneda, M Kasai, Y Itoh, K Iwabuchi, K Onoé	Microbiology and Immunology	1997
CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection R M Reul, J C Fang, M D Denton, C Geehan, C Long, R N Mitchell, P Ganz, D M Briscoe	Transplantation	1997
CD40 expression by human peripheral blood eosinophils Y Ohkawara, KG Lim, Z Xing, M Glibetic, K Nakano, J Dolovich, K Croitoru, PF Weller, M Jordana	Journal of Clinical Investigation	1996
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes M Koshy, D Berger, MK Crow	Journal of Clinical Investigation	1996
Therapeutic potential for blockade of the CD40 ligand, gp39 JE Buhlmann, RJ Noelle	Journal of Clinical Immunology	1996
CD40 is functionally expressed on human keratinocytes RW Denfeld, D Hollenbaugh, A Fehrenbach, JM Weiss, A Leoprechting, B Mai, U Voith, E Schöpf, A Aruffo, JC Simon	European Journal of Immunology	1996
IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39 TM Foy, A Aruffo, J Bajorath, JE Buhlmann, RJ Noelle	Annual Review of Immunology	1996
Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway K Karmann, CC Hughes, WC Fanslow, JS Pober	European Journal of Immunology	1996
Protective Role of CD40 in Leishmania major Infection at Two Distinct Phases of Cell-Mediated Immunity M Kamanaka, P Yu, T Yasui, K Yoshida, T Kawabe, T Horii, T Kishimoto, H Kikutani	Immunity	1996
CD40 and Its Ligand in Host Defense RJ Noelle	Immunity	1996
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major KA Campbell, PJ Ovendale, MK Kennedy, WC Fanslow, SG Reed, CR Maliszewski	Immunity	1996
CD40 and the Effect of Anti-CD40-Binding on Human Multiple Myeloma Clonogenicity AW Tong, MJ Stone	Leukemia & Lymphoma	1996
Interleukin-12 Production by Dendritic Cells BL Kelsall, E Stüber, M Neurath, W Strober	Annals of the New York Academy of Sciences	1996
CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages MK Kennedy, KS Picha, WC Fanslow, KH Grabstein, MR Alderson, KN Clifford, WA Chin, KM Mohler	European Journal of Immunology	1996
The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells ND Griggs, SS Agersborg, RJ Noelle, JA Ledbetter, PS Linsley, KS Tung	Journal of Experimental Medicine	1996
Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection WW Hancock, MH Sayegh, XG Zheng, R Peach, PS Linsley, LA Turka	Proceedings of the National Academy of Sciences	1996
Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion E Stuber, W Strober, M Neurath	Journal of Experimental Medicine	1996
BYSTANDER INJURY OF HOST LYMPHOID TISSUE DURING MURINE GRAFT-VERSUS-HOST DISEASE IS MEDIATED BY NITRIC OXIDE1: RA Hoffman, JM Langrehr, LA Berry, DA White, NC Schattenfroh, SA MaCarthy, RL Simmons	Transplantation	1996
Blood Cell Biochemistry AD Whetton, J Gordon		1996
CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression K Karmann, CC Hughes, J Schechner, WC Fanslow, JS Pober	Proceedings of the National Academy of Sciences	1995
Cleavable CD40Ig fusion proteins and the binding to sgp39 D Hollenbaugh, J Douthwright, V McDonald, A Aruffo	Journal of Immunological Methods	1995
In the absence of a CD40 signal, B cells are tolerogenic J E Buhlmann, T M Foy, A Aruffo, K M Crassi, J A Ledbetter, W R Green, J C Xu, L D Shultz, D Roopesian, R A Flavell	Immunity	1995
Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment BR Blazar, R Korngold, DA Vallera	Journal of immunology (Baltimore, Md. : 1950)	1994

Advertisement